Companies: 10,795·Total market cap: $144.5T
Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZIANASDAQHealthcare● Active
$11.40
+$0.41(+3.73%)
Market Cap$18465617
P/E Ratio
52W High$17.4
52W Low$4.86

Kazia Therapeutics Limited(KZIA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · KZIA · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$0.04M$2.31M$0.00M$0.01M$15.18M
Cost of Revenue$0.00M$0.00M$0.00M$0.00M$0.00M
Gross Profit$0.04M$2.31M$0.00M$0.01M$15.18M
Gross Margin %(computed)100.00%100.00%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$7.33M$17.38M$15.56M$20.17M$14.54M
G&A Expenses$8.72M$13.56M$8.58M$5.11M$7.02M
Total Operating Expenses$14.26M$30.77M$24.12M$25.41M$21.56M
Operating Income($14.22M)($28.46M)($24.12M)($25.40M)($6.38M)
Operating Margin %(computed)-41.99%
Interest Income$0.07M$0.01M$0.02M$0.00M$0.04M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($22.45M)($27.05M)($20.74M)($25.38M)($8.90M)
Income Tax Expense($1.75M)($0.27M)($0.27M)($0.37M)($0.48M)
Net Income($20.70M)($26.78M)($20.47M)($25.01M)($8.42M)
Net Margin %(computed)-55.46%
Per Share & EBITDA
EPS (Basic)$-18.90$-55.00$-55.00$-95.00$-35.80
Wtd Avg Shares1.10M0.48M0.37M0.27M0.24M
EBITDA($13.28M)($26.59M)($22.28M)($23.52M)($5.11M)
EBITDA Margin %(computed)-33.66%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · AUD · M

深入了解Kazia Therapeutics Limited

关于Kazia Therapeutics Limited(KZIA)损益表

Kazia Therapeutics Limited(KZIA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,KZIA实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.02B)(净利率-49290.48%)。

常见问题

KZIA · 4 问

Kazia Therapeutics Limited(KZIA)2025财年营收为$0.00B,同比down98.2%。

KZIA revenueKZIA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09